Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Drugs binding

Fig. 15. Drug binding sites associated with the GABA receptor—channel complex where (— -) represents the carbon backbone of GABA agonists. Fig. 15. Drug binding sites associated with the GABA receptor—channel complex where (— -) represents the carbon backbone of GABA agonists.
The cleft where this drug binds is inside the jelly roll barrel of subunit VPl. Most spherical viruses of known structure have the tip of one type of subunit close to the fivefold symmetry axes (Figure 16.15a). In all the picor-naviruses this position is, as we have described, occupied by the VPl subunit. Two of the four loop regions at the tip are considerably longer in VPl than in the other viral coat proteins. These long loops at the tips of VPl subunits protrude from the surface of the virus shell around its 12 fivefold axes (Figure 16.15b). [Pg.337]

Figure 16.16 Schematic diagrams Illustrating the binding of an antiviral agent to human rhlnovirus strain 14. (a) The drug binds in a hydrophobic pocket of VPl below the floor of the canyon, (b) Schematic diagram of VPl Illustrating the pocket in the jelly roll barrel where the drug binds. (Adapted from T.J. Smith et al.. Science 233 1286-1293, 1986.)... Figure 16.16 Schematic diagrams Illustrating the binding of an antiviral agent to human rhlnovirus strain 14. (a) The drug binds in a hydrophobic pocket of VPl below the floor of the canyon, (b) Schematic diagram of VPl Illustrating the pocket in the jelly roll barrel where the drug binds. (Adapted from T.J. Smith et al.. Science 233 1286-1293, 1986.)...
It is amazing to note that complex processes such as drug binding to protein, activation of cells, and observation of syncytial cellular response should apparently so closely follow a model based on these simple concepts. This was not lost on A. J. Clark in his treatise on drug receptor theory The Mode of Action of Drugs on Cells [4] ... [Pg.12]

Quinidine, the classical class IA drug, binds to the open state oftheNa+ channel, and prolongs the action potential by block of the delayed rectifier-. In higher concentrations, L-type Ca2+ channels are inhibited. Quinidine exerts antimuscarinic effects, thereby accelerating AV-nodal... [Pg.98]

Verapamil is a phenylalkylamine which blocks L-type Ca2+ channels in a use-dependent manner. The drug binds to the inactivated state of the channel. Diltiazem is a benzothiazepine derivative with a profile of action most similar to that of verapamil. [Pg.100]

Striessnig J, Grabner M, Mitterdorfer J et al (1998) Structural basis of drug binding to L Ca2+ channels. Trends Pharmacol Sci 19 108-115... [Pg.300]

Cliolestyramine (Questran) and colestipol (Colestid) are examples of bile acid sequestrants. Bile, which is manufactured and secreted by the liver and stored in the gallbladder, emulsifies fat and lipids as these products pass through the intestine Once emulsified, fats and lipids are readily absorbed in the intestine These drug bind to bile acids to form an insoluble substance that cannot be absorbed by the intestine, so it is secreted in the feces. With increased loss of bile acids, the liver uses cholesterol to manufacture more bile This is followed by a decrease in cholesterol levels. [Pg.408]

Alkylating drugp interfere with the process of cell division of malignant and normal cells. The drug binds with DNA, causing breaks and preventing DNA replication. [Pg.591]

DHP drugs bind allosterically. The open L-channel is somehat more permeable to the Ba ion than to the Ca ion but is very much less permeable to the Na ion. Nonetheless, because Na ion concentrations are so much higher than Ca ion concentrations, the actual fraction of charge carried by the two ions is not always so clear. There are a number of states that the L-channel can be in, aside from simply being open or closed. It is the distribution of L-channel molecules among the various states that is influenced by transmembrane voltage. From another view the rate constants between the states are functions of the transmembrane voltage. [Pg.187]

Han Nl, Lee YS, Choi H, Choi JY, Yun SK, Cho SH, Han JY, Yang JM, Ahn BM, Choi SW, Lee CD, Cha SB, Sun HS, Park DH (2002) PCNA expression and electron microscopic study of acinus-forming hepatocytes in chronic hepatitis B. Korean J Intern Med 17 100-106 Herve F, Urien S, Albengres E, Duche JC, TiUement IP (1994) Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding. Qin Pharmacokinet 26 44-58... [Pg.47]

Certain drugs bind to microtubules and thus interfere with their assembly or disassembly. These include colchicine (used for treatment of acute gouty arthritis), vinblastine (a vinca alkaloid used for treating certain types of cancer), paclitaxel (Taxol) (effective against ovarian cancer), and griseoflilvin (an antifungal agent). [Pg.577]

Many drugs bind to cholinergic receptors but few of them enter the brain and those that do are not noted for their effects. [Pg.128]

Roberts,J.(1993)Thekineticpropertiesof Au(I) drug binding to serum albumin and selenium-glutathione peroxidase and their significance for rheumatoid arthritis. Ph.D. thesis, University-Milwaukee. [Pg.317]

Another important type of physical chemical interaction that may alter absorption is that of drug binding or adsorption onto the surface of another material. As with complexation and micellarization, adsorption will reduce the effective concentration gradient between gut fluids and the bloodstream, which is the driving force for passive absorption. While adsorption frequently reduces the rate of absorption, the interaction is often readily reversible and will not affect the extent of absorption. A major exception is adsorption onto charcoal, which in many cases appears to be irreversible, at least during the time of residence within the GIT. As a result, charcoal often reduces the extent of drug absorption. Indeed, this fact... [Pg.63]

In the context of synthesis and exchange reactions of biodegradable drug-binding matrices, starch trisuccinic acid was loaded via imidazolides with amines such as n-butylamine, morpholine, 4-aminobenzoic acid, or 3,4-dihydroxyphenylalanine to prepare the respective amides in high yields [160] an example is presented below. [Pg.127]

The examples above serve to illustrate that the conformational dynamics of enzyme turnover create multiple, specific binding pocket configurations throughout the reaction pathway, each representing a distinct opportunity for drug binding and inhibition. [Pg.14]

Most drugs bind to their enzyme target through reversible interactions. [Pg.48]


See other pages where Drugs binding is mentioned: [Pg.314]    [Pg.6]    [Pg.87]    [Pg.114]    [Pg.410]    [Pg.161]    [Pg.234]    [Pg.296]    [Pg.302]    [Pg.547]    [Pg.638]    [Pg.750]    [Pg.957]    [Pg.62]    [Pg.141]    [Pg.338]    [Pg.193]    [Pg.501]    [Pg.538]    [Pg.108]    [Pg.228]    [Pg.69]    [Pg.108]    [Pg.45]    [Pg.221]    [Pg.729]    [Pg.301]    [Pg.981]    [Pg.140]    [Pg.142]    [Pg.8]    [Pg.242]   
See also in sourсe #XX -- [ Pg.30 ]

See also in sourсe #XX -- [ Pg.80 , Pg.81 ]

See also in sourсe #XX -- [ Pg.87 ]

See also in sourсe #XX -- [ Pg.87 ]

See also in sourсe #XX -- [ Pg.3 , Pg.1702 ]




SEARCH



Acidic drugs binding affinity

Acidic drugs binding affinity data

Albumin bound drugs protein binding

Albumin, drug binding

Allosteric binding, drug interactions

Antiepileptic drugs protein binding

Assays binding anti-drug antibodies

Binding interactions, drug receptor

Binding mode analysis identical twin drugs

Binding of Pt-antitumor Drugs to DNA

Binding of drug

Binding of drugs to HSA

Binding, drug-receptor distribution affected

Binding, drug-receptor interactions based

Blood plasma proteins, drug binding

Covalent binding drug toxicity

Covalent binding drug-related material

Covalent drug binding

DNA-binding drugs

Definitions of Drug-Receptor Binding Interactions

Drug binding assays, protein

Drug binding studies

Drug binding, to proteins

Drug binding: protein polymorphism

Drug concentration protein binding

Drug covalent binding study

Drug development protein binding pocket

Drug distribution plasma protein binding

Drug distribution protein binding

Drug interactions plasma protein binding

Drug interactions tissue binding

Drug molecules binding affinities

Drug physicochemical binding assays

Drug plasma binding

Drug-Receptor Binding Energies

Drug-binding sites

Drug-protein binding

Drug-receptor binding

Drug-receptor interactions cooperative binding

Drug-target binding forces

Drug-target binding forces fields

Drug-target binding forces molecular mechanics force

Drugs Binding to Hair

Drugs plasma protein binding and

Experimental Quantification of Drug-Receptor Binding Interactions

Force fields drug-target binding forces

Glycine (Gly drugs binding to receptors

Groove binding drugs

Hormone receptor drug binding

Human Serum Albumin-Drug Binding Affinity Based on Liquid Chromatography

Human drug-binding site

Human serum albumin drugs that bind

Human serum albumin-drug binding affinity

Human serum albumin-drug binding constant

Measurement of HSA-Drug Binding Affinity

Melanin Play a Role in Drug Binding

Mucins drug binding

Multiple drug binding sites

Nuclear hormone receptors drug binding

Plasma Protein Binding of Acidic Drugs

Plasma protein binding, free drug principle

Plasma proteins altered drug binding

Plasma proteins, binding of drugs

Plasma proteins, drug-binding

Protein binding of acidic drugs

Protein binding, drug interactions

Protein binding, of drugs

Radioligand binding, drug discovery

Receptor binding drug design

Role of Covalent Binding in Drug Toxicity

Serum protein binding sulfonamide drugs

Serum proteins, drug binding

Structural Interpretation of Drug Binding

Thyroid hormone drugs affecting binding

Tissue binding of drugs

Viral binding inhibiting drugs

© 2024 chempedia.info